MRC Laboratory of Molecular Biology, Cambridge, UK.
EMBO J. 2010 Nov 17;29(22):3797-809. doi: 10.1038/emboj.2010.243. Epub 2010 Oct 1.
Rhomboids are intramembrane proteases that use a catalytic dyad of serine and histidine for proteolysis. They are conserved in both prokaryotes and eukaryotes and regulate cellular processes as diverse as intercellular signalling, parasitic invasion of host cells, and mitochondrial morphology. Their widespread biological significance and consequent medical potential provides a strong incentive to understand the mechanism of these unusual enzymes for identification of specific inhibitors. In this study, we describe the structure of Escherichia coli rhomboid GlpG covalently bound to a mechanism-based isocoumarin inhibitor. We identify the position of the oxyanion hole, and the S₁- and S₂'-binding subsites of GlpG, which are the key determinants of substrate specificity. The inhibitor-bound structure suggests that subtle structural change is sufficient for catalysis, as opposed to large changes proposed from previous structures of unliganded GlpG. Using bound inhibitor as a template, we present a model for substrate binding at the active site and biochemically test its validity. This study provides a foundation for a structural explanation of rhomboid specificity and mechanism, and for inhibitor design.
菱形蛋白酶是一种跨膜丝氨酸蛋白酶,其活性依赖于丝氨酸和组氨酸残基组成的催化二联体。该酶在原核生物和真核生物中均高度保守,通过调控细胞间信号转导、寄生虫入侵宿主细胞和线粒体形态等多种生物学过程而发挥作用。鉴于菱形蛋白酶具有广泛的生物学意义和潜在的医学应用价值,解析其结构和功能对于开发针对该酶的特异性抑制剂具有重要意义。本研究解析了与机制性异羟肟酸抑制剂共价结合的大肠杆菌菱形蛋白酶 GlpG 的晶体结构,确定了 GlpG 的氧阴离子穴和 S₁-、S₂'-底物结合口袋的位置,这些是决定底物特异性的关键因素。抑制剂结合结构表明,催化作用只需较小的结构变化,而不是先前报道的无配体 GlpG 结构所提出的较大变化。我们以结合抑制剂为模板,提出了活性位点的底物结合模型,并通过生化实验验证了其合理性。本研究为解释菱形蛋白酶的特异性和作用机制以及抑制剂设计提供了结构基础。